BEAM
Price
$21.15
Change
-$0.88 (-3.99%)
Updated
Jul 11, 04:59 PM (EDT)
Capitalization
2.16B
32 days until earnings call
VRDN
Price
$17.04
Change
-$0.09 (-0.53%)
Updated
Jul 11, 04:59 PM (EDT)
Capitalization
1.39B
26 days until earnings call
Interact to see
Advertisement

BEAM vs VRDN

Header iconBEAM vs VRDN Comparison
Open Charts BEAM vs VRDNBanner chart's image
Beam Therapeutics
Price$21.15
Change-$0.88 (-3.99%)
Volume$39.23K
Capitalization2.16B
Viridian Therapeutics
Price$17.04
Change-$0.09 (-0.53%)
Volume$7.27K
Capitalization1.39B
BEAM vs VRDN Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. VRDN commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and VRDN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (BEAM: $22.03 vs. VRDN: $17.13)
Brand notoriety: BEAM and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 162% vs. VRDN: 73%
Market capitalization -- BEAM: $2.16B vs. VRDN: $1.39B
BEAM [@Biotechnology] is valued at $2.16B. VRDN’s [@Biotechnology] market capitalization is $1.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • VRDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than VRDN.

Price Growth

BEAM (@Biotechnology) experienced а +10.09% price change this week, while VRDN (@Biotechnology) price change was +9.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.52%. For the same industry, the average monthly price growth was +16.95%, and the average quarterly price growth was +21.18%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

VRDN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+9.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.16B) has a higher market cap than VRDN($1.39B). VRDN (-10.642) and BEAM (-11.169) have similar YTD gains . VRDN has higher annual earnings (EBITDA): -304.76M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. VRDN (637M). VRDN has less debt than BEAM: VRDN (21.2M) vs BEAM (158M). BEAM has higher revenues than VRDN: BEAM (63.6M) vs VRDN (302K).
BEAMVRDNBEAM / VRDN
Capitalization2.16B1.39B155%
EBITDA-399.03M-304.76M131%
Gain YTD-11.169-10.642105%
P/E RatioN/AN/A-
Revenue63.6M302K21,060%
Total Cash1.22B637M192%
Total Debt158M21.2M745%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMVRDN
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBLGX64.75N/A
N/A
ClearBridge Large Cap Growth A
SEQAX17.34N/A
N/A
NAA World Equity Income A
WIEFX16.08N/A
N/A
Boston Trust Walden International Eq
EMRSX18.77N/A
N/A
JPMorgan Emerging Mkts Rsrch Enh Eq R6
HWSZX75.11N/A
N/A
Hotchkis & Wiley Small Cap Value Z